Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement

Clinical trial NCT06923072 · RECRUITING

Trial details

NCT number: NCT06923072
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Kohlmeier-Degos Disease Malignant Atrophic Papulosis Degos Disease Papulosis, Malignant Atrophic

Start date: 2026-02-18
Primary completion: 2030-12-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.